Loading organizations...
Loading organizations...
Biopharmaceutical company developing therapies for renal diseases.
Alebund Pharmaceuticals has raised $60.0M across 1 funding round.
Alebund Pharmaceuticals has raised $60.0M in total across 1 funding round.
Alebund Pharmaceuticals has raised $60.0M in total across 1 funding round.
Alebund Pharmaceuticals's investors include Quan Capital, 3E Bioventures Capital, Lilly Asia Ventures, Med-Fine Capital, Sherpa Healthcare Partners.
Alebund Pharmaceuticals has raised $60.0M across 1 funding round. Most recently, it raised $60.0M Series B in May 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| May 10, 2021 | $60.0M Series B | Quan Capital | 3E Bioventures Capital, Lilly Asia Ventures, Med-Fine Capital, Sherpa Healthcare Partners |